Avanzanite Bioscience (@AvanzaniteBio) header
Avanzanite Bioscience (@AvanzaniteBio) profile picture

Avanzanite Bioscience

@AvanzaniteBio

Redefining the orphan drug landscape & unlocking energy for patients with rare diseases in Europe.

 Amsterdam, the Netherlands
avanzanite.com
Joined November 2022
  • Tweets9
  • Following4
  • Followers7
2Media
Photo by Avanzanite Bioscience (@AvanzaniteBio)Photo by Avanzanite Bioscience (@AvanzaniteBio)
“Together with my colleagues in Germany and Europe, we have a great opportunity and mission to significantly improve the lives of people with rare diseases.” businesswire.com/news/home/2… #innovation #orphandrugs #raredisease #dRTA #nephrology #pediatricnephrology #pediatrics #kidney
Avanzanite Bioscience Further Strengthens Leadership Team With Country Manager of Germany

Avanzanite Bioscience Further Strengthens Leadership Team With Country Manager of Germany

Avanzanite Bioscience Further Strengthens Leadership Team With Country Manager of Germany

businesswire.com
1
1
98
2023 Knights for Rare: The Acanthamoeba Keratitis Eye Foundation youtu.be/Z3GAYgnnaDQ via @YouTube #raredisease #AKeyefoundation
2023 Knights for Rare: The Acanthamoeba Keratitis Eye Foundation

2023 Knights for Rare: The Acanthamoeba Keratitis Eye Foundation

On 21 March in Amsterdam, Avanzanite Bioscience started the traditi...

youtube.com
73
Today is #rarediseaseday and we are excited to share that we've partnered with #Advicenne in distal Renal Tubular Acidosis (#dRTA). businesswire.com/news/home/2… #raredisease #patientsfirst #orphandrugs
1
1
498
Avanzanite Bioscience retweeted
Adam Andrzej Plich (@AdamPlich) profile picture
Adam Andrzej Plich@AdamPlich19 Jan 2023
READ more about our partnership with SIFI in #acanthamoebakeratitis #RareDiseases #orphandrugs #innovation #patientsfirst prnewswire.com/news-releases…
SIFI ANNOUNCES LICENSE AGREEMENT WITH AVANZANITE BIOSCIENCE FOR AKANTIOR®

SIFI ANNOUNCES LICENSE AGREEMENT WITH AVANZANITE BIOSCIENCE FOR AKANTIOR®

/PRNewswire/ -- SIFI, a leading international ophthalmic company headquartered in Italy, today announced that it has partnered with Avanzanite Bioscience...

prnewswire.com
1
1
65
Read about our mission in the latest edition of @Biotech_finance which featured an interview with Founder & CEO @AdamPlich #orphandrugs #rarediseases #patientaccess #innovation
Image from Avanzanite Bioscience (@AvanzaniteBio)
Avanzanite Bioscience retweeted
SKC Consulting (@consulting_skc) profile picture
SKC Consulting@consulting_skc30 Nov 2022
Prof. Dr. Schönermark berichtet im Profcast über die drei dominierenden Themen des World Orphan Drug Congress Europe und führt live Interviews mit @AlexionPharma und @AvanzaniteBio. Jetzt reinhören unter skc-beratung.de/de/insights/…. #WODC @orphan_drugs #orphandrugs #rarediseases
Image from SKC Consulting (@consulting_skc)
1
2
Avanzanite Bioscience looks to commercialize innovative medicines for rare diseases in Europe labiotech.eu/trends-news/ava… via @Labiotech_eu #rarediseases #orphandrugs #innovation
Avanzanite Bioscience looks to commercialize innovative medicines for rare diseases in Europe

Avanzanite Bioscience looks to commercialize innovative medicines for rare diseases in Europe

Avanzanite has officially launched its commercial-stage enterprise to expand patient access to medicines for rare diseases in Europe.

labiotech.eu
1
BRIEF—New business model to boost orphan drug access in Europe thepharmaletter.com/in-brief…

BRIEF—New business model to boost orphan drug access in Europe

A Dutch company with a novel business model, Avanzanite Bioscience, is looking to expand patient access to medicines for rare diseases in Europe.

thepharmaletter.com
Avanzanite Bioscience retweeted
Adam Andrzej Plich (@AdamPlich) profile picture
Adam Andrzej Plich@AdamPlich15 Nov 2022
Launching Avanzanite Bioscience Today – Find out WHY: youtu.be/TgKgfuPvbjQ #orphandrugs #rarediseases #patientaccess #innovation #corporatelaunch
1
Load more